HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul H Cottu Selected Research

onapristone

10/2020Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on Hepatotoxicity.
1/2018Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul H Cottu Research Topics

Disease

11Breast Neoplasms (Breast Cancer)
01/2022 - 01/2002
5Neoplasms (Cancer)
01/2022 - 11/2011
2Endometrial Neoplasms (Endometrial Cancer)
10/2020 - 01/2018
2Brain Neoplasms (Brain Tumor)
04/2011 - 07/2009
1Weight Loss (Weight Reduction)
03/2022
1Obesity
01/2022
1Body Weight (Weight, Body)
01/2022
1Neoplasm Metastasis (Metastasis)
10/2020
1Prostatic Neoplasms (Prostate Cancer)
10/2020
1Necrosis
11/2011
1Thrombosis (Thrombus)
11/2011
1Wounds and Injuries (Trauma)
11/2011
1Hand-Foot Syndrome
07/2009
1Headache (Headaches)
07/2009
1Anemia
07/2009
1Mucositis
07/2009
1Nausea
07/2009

Drug/Important Bio-Agent (IBA)

2onapristoneIBA
10/2020 - 01/2018
2Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 01/2018
2Hormones (Hormone)IBA
01/2019 - 04/2011
2Phenobarbital (Luminal)FDA Link
01/2019 - 01/2017
1Biomarkers (Surrogate Marker)IBA
03/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2020
1Alanine (L-Alanine)FDA Link
10/2020
1Alanine Transaminase (SGPT)IBA
10/2020
1BilirubinIBA
10/2020
1Oral ContraceptivesIBA
10/2020
1Delayed-Action PreparationsIBA
10/2020
1Pharmaceutical PreparationsIBA
10/2020
1TamoxifenFDA LinkGeneric
01/2020
1eribulinFDA Link
12/2016
1Bevacizumab (Avastin)FDA Link
11/2011
1ErbB Receptors (EGF Receptor)IBA
10/2010
1Trastuzumab (Herceptin)FDA Link
10/2010
1Capecitabine (Xeloda)FDA Link
07/2009

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2022 - 01/2002
4Therapeutics
10/2020 - 11/2011
2Adjuvant Chemotherapy
01/2022 - 01/2002
1Caloric Restriction
03/2022
1Duration of Therapy
01/2018
1Neoadjuvant Therapy
01/2017
1Catheters
11/2011
1Drug Tapering
07/2009
1Radiotherapy
07/2009